These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 10992115)

  • 21. [MSA update].
    Tsuji S
    Rinsho Shinkeigaku; 2005 Nov; 45(11):821-3. PubMed ID: 16447735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology.
    Gilman S; Low P; Quinn N; Albanese A; Ben-Shlomo Y; Fowler C; Kaufmann H; Klockgether T; Lang A; Lantos P; Litvan I; Mathias C; Oliver E; Robertson D; Schatz I; Wenning G
    Clin Auton Res; 1998 Dec; 8(6):359-62. PubMed ID: 9869555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autonomic failure in neurodegenerative disorders.
    Kaufmann H; Biaggioni I
    Semin Neurol; 2003 Dec; 23(4):351-63. PubMed ID: 15088256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosing multiple system atrophy with greater accuracy: combined analysis of the clonidine-growth hormone test and external anal sphincter electromyography.
    Lee EA; Kim BJ; Lee WY
    Mov Disord; 2002 Nov; 17(6):1242-7. PubMed ID: 12465063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy.
    Litvan I; Booth V; Wenning GK; Bartko JJ; Goetz CG; McKee A; Jankovic J; Jellinger K; Lai EC; Brandel JP; Verny M; Chaudhuri KR; Pearce RK; Agid Y
    J Neural Transm (Vienna); 1998; 105(2-3):217-27. PubMed ID: 9660099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple system atrophy.
    Fanciulli A; Stankovic I; Krismer F; Seppi K; Levin J; Wenning GK
    Int Rev Neurobiol; 2019; 149():137-192. PubMed ID: 31779811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamic effects of clonidine in two contrasting models of autonomic failure: multiple system atrophy and pure autonomic failure.
    Young TM; Asahina M; Watson L; Mathias CJ
    Mov Disord; 2006 May; 21(5):609-15. PubMed ID: 16404729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Respiratory insufficiency as the primary presenting symptom of multiple-system atrophy.
    Glass GA; Josephs KA; Ahlskog JE
    Arch Neurol; 2006 Jul; 63(7):978-81. PubMed ID: 16831967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expanding concept of clinical conditions and symptoms in multiple system atrophy].
    Watanabe H; Riku Y; Nakamura T; Hara K; Ito M; Hirayama M; Yoshida M; Katsuno M; Sobue G
    Rinsho Shinkeigaku; 2016 Jul; 56(7):457-64. PubMed ID: 27356737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Camptocormia or Pisa syndrome in multiple system atrophy.
    Sławek J; Derejko M; Lass P; Dubaniewicz M
    Clin Neurol Neurosurg; 2006 Oct; 108(7):699-704. PubMed ID: 16112411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis and therapy of multiple system atrophy].
    Wenning GK; Seppi K
    Praxis (Bern 1994); 2001 Jun; 90(23):1035-40. PubMed ID: 11447723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of cortico-spinal tract impairment in multiple system atrophy using transcranial magnetic stimulation.
    Eusebio A; Azulay JP; Witjas T; Rico A; Attarian S
    Clin Neurophysiol; 2007 Apr; 118(4):815-23. PubMed ID: 17317305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The validity of a hyperventilation test for an investigation of autonomic failure: assessment in patients with multiple system atrophy and Parkinson's disease.
    Deguchi K; Sasaki I; Ikeda K; Shimamura M; Urai Y; Tsukaguchi M; Touge T; Takeuchi H; Kuriyama S
    Int J Clin Pract; 2006 Dec; 60(12):1542-7. PubMed ID: 16669828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Towards more efficient clinical trials for multiple system atrophy in Japan].
    Ichikawa Y
    Brain Nerve; 2012 Oct; 64(10):1141-9. PubMed ID: 23037604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia.
    Pellecchia MT; Pivonello R; Salvatore E; Faggiano A; Barone P; De Michele G; Lombardi G; Colao A; Filla A
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):428-33. PubMed ID: 15807873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Multiple system atrophy: the beginning of a new era in the history of neurodegenerative diseases].
    Papp M; Kovács T
    Ideggyogy Sz; 2006 Sep; 59(9-10):308-20. PubMed ID: 17165375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple system atrophy: an update.
    Wenning GK; Geser F; Stampfer-Kountchev M; Tison F
    Mov Disord; 2003 Sep; 18 Suppl 6():S34-42. PubMed ID: 14502654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proposed neuroimaging criteria for the diagnosis of multiple system atrophy.
    Brooks DJ; Seppi K;
    Mov Disord; 2009 May; 24(7):949-64. PubMed ID: 19306362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple system atrophy.
    Bhidayasiri R; Ling H
    Neurologist; 2008 Jul; 14(4):224-37. PubMed ID: 18617848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic strategies in multiple system atrophy.
    Wenning GK; Geser F; Poewe W
    Mov Disord; 2005 Aug; 20 Suppl 12():S67-76. PubMed ID: 16092094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.